venture capital

Lightstone Ventures Raises $375M Fund to Invest in Early Stage Biotech and Medtech Companies

What You Should Know: – Lightstone Ventures today announced the closing of Lightstone Ventures III with $375M in capital commitments, to invest in early-stage companies developing high-impact therapeutics and technologies. – The new fund was oversubscribed, exceeding the firm’s targeted raise, and included strong support from both new and existing limited partners. With the closing …

Lightstone Ventures Raises $375M Fund to Invest in Early Stage Biotech and Medtech Companies Read More »

Policies|Techies|VCs: What’s Next For Health Care–Virtual Conference is Sept 7-10

Policies|Techies|VCs: What’s Next For Health Care? is the conference bringing together the CEOs of the next generation of virtual & real-life care delivery, and all the permutations thereof. You can register here or learn how to sponsor. This is a big week. We are one week out and we’ve started pre-recording a few sessions and they’ve been fascinating. Keynotes …

Policies|Techies|VCs: What’s Next For Health Care–Virtual Conference is Sept 7-10 Read More »

‘Nos complica la vida’: muchas empresarias deben soportar las comparaciones con Elizabeth Holmes, la fundadora de Theranos

Numerosas emprendedoras dicen que suelen compararlas con Holmes, la fundadora de Theranos, que pronto enfrentará un juicio por fraude.

‘Nos complica la vida’: muchas empresarias deben soportar las comparaciones con Elizabeth Holmes, la fundadora de Theranos

Numerosas emprendedoras dicen que suelen compararlas con Holmes, la fundadora de Theranos, que pronto enfrentará un juicio por fraude.

‘Nos complica la vida’: muchas empresarias deben soportar las comparaciones con Elizabeth Holmes, la fundadora de Theranos

Numerosas emprendedoras dicen que suelen compararlas con Holmes, la fundadora de Theranos, que pronto enfrentará un juicio por fraude.

INVEST Digital Health preview: The Next Phase of Digital Health Investment

INVEST Digital Health is set for September 20-23, and held in collaboration with Medical Alley. It brings together innovative investors across the healthcare spectrum, prominent industry players and the most promising digital health startups.

THCB Spotlights: Marta Zanchi, Founder & Managing Partner at Nina Capital

Today on THCB Spotlight, Matthew sits down with Marta Zanchi, who is the founder and Managing Partner at Nina Capital. Nina Capital is a micro venture capital firm in Barcelona, and in this interview, Matthew asks Marta about her decision to move from Silicon Valley to Barcelona and start this fund. Marta talks us through …

THCB Spotlights: Marta Zanchi, Founder & Managing Partner at Nina Capital Read More »

INVEST Precision Medicine Conference Video: Pitch Perfect Life Sciences

Presentations by precision medicine startups and growth stage companies across diagnostics, biopharma and medtech. Judges are from Global Founders Capital, Dreamit Ventures, and Silicon Valley Bank

The Catalyst @ Health 2.0/Wipfli State of Digital Health Survey

By MATTHEW HOLT & ELIZABETH BROWN Last year was a remarkable time for digital health. Obviously it was pretty unusual and tragic for the world in general as the COVID-19 pandemic continued to wreak havoc. We mourn those lost, and we praise our front line health workers and scientists. But for digital health companies, in …

The Catalyst @ Health 2.0/Wipfli State of Digital Health Survey Read More »

Dr. Micky Tripathi on interoperability, health equity & how his work with VCs will help him lead the ONC

In a wide-ranging interview, the National Coordinator for Health IT Dr. Micky Tripathi discussed his career and how his varied experiences have expanded his perspective. He also spoke about ONC’s plans for the future, which include “evangelizing” about the opportunities the federal interoperability rules will create for the industry.

Investment in healthcare is soaring, but entrepreneurs must be wary of over-capitalizing  

The Covid-19 pandemic pushed the already impressive growth in healthcare investing to new heights, with valuations on the rise and companies gaining access to vast sums of money. But speakers at a MedCity INVEST panel warned that raising more capital than needed is not always a good thing.

Q1 2021 Health IT/Digital Health PC/VE, M&A, IPOs/ SPACs Activity

The first quarter of 2021 has been one of investor optimism as the vaccine rollout continues ahead of expectations and economic activity begins to accelerate in response.  Within the Health IT industry, the already strong investment and M&A trends seen in 2020 have only accelerated.  Over the course of the quarter, we observed $7 billion in private …

Q1 2021 Health IT/Digital Health PC/VE, M&A, IPOs/ SPACs Activity Read More »

Life Sciences Firm OrbiMed Raises $3.5B Across Private Investment Funds

What You Should Know: Life sciences investment firm OrbiMed announced $3.5 billion in commitments for its latest private investment funds, including $1.5 billion for OrbiMed Private Investments VIII, $800 million for OrbiMed Asia Partners IV, and $1.2 billion for OrbiMed Royalty & Credit Opportunities III. The three new funds include a broad range of medical …

Life Sciences Firm OrbiMed Raises $3.5B Across Private Investment Funds Read More »

Executive Hires: Walgreens Appoints New CEO, Cityblock Health, Innovaccer, Others

Walgreens appoints Rosalind (Roz) Brewer as the company’s Chief Executive Officer, effective on March 15, 2021. Brewer will also join the WBA Board of Directors upon assuming the role. She succeeds Stefano Pessina who, as previously announced, will transition to the role of Executive Chairman of the Board of WBA. Brewer, 58, will become the …

Executive Hires: Walgreens Appoints New CEO, Cityblock Health, Innovaccer, Others Read More »

UK biotech investment at record levels amid COVID-19

New figures have confirmed that the UK’s biotech sector received a massive boost from the COVID-19 pandemic last year, with investment levels soaring to £2.8 billion ($3.8 billion) from a level of £1.3 billion in 2019. That makes 2020 a new record year for the sector, exceeding the previous investment high of £2.2 billion in …

UK biotech investment at record levels amid COVID-19 Read More »

3 Steps to Maintain Telehealth’s Momentum Post-Pandemic

In the face of COVID-19, healthcare witnessed how crises can become the long-awaited push for creativity and innovation that the industry needs. When our healthcare infrastructure’s weaknesses were exposed, telehealth helped to stitch them up, with the number of telehealth claims increasing 8,336% nationally from April 2019 to April 2020. Out of need, patients quickly …

3 Steps to Maintain Telehealth’s Momentum Post-Pandemic Read More »

Transformation Capital Launches $500M Digital Health Fund

What You Should Know: – Transformation Capital Partners, L.P. (“Transformation Capital”) announced the launches of it’s $500M growth equity fund, Transformation Capital Fund II, L.P. – The new fund will focus on investing between $10 to $30M in commercial-stage digital health companies and technology-enabled service businesses that are improving the healthcare system. – Led by …

Transformation Capital Launches $500M Digital Health Fund Read More »

Xealth’s CEO Shares Impact of Digital Health in 2020 and What’s Ahead in 2021

Mike McSherry, CEO & Co-founder of Xealth HIT Consultant sat down with Mike McSherry, CEO, and co-founder of Seattle-based digital prescription platform Xealth to discuss digital health lessons learned in 2020 and what we can expect in 2021. As Xealth’s CEO, Mike also works with Duke Health, UPMC, Atrium Health, and The Froedtert & the …

Xealth’s CEO Shares Impact of Digital Health in 2020 and What’s Ahead in 2021 Read More »

VC fund dedicated to psychedelic meds launches in UK

In the last few years, biopharma companies focusing on psychedelic medicines have been springing up like mushrooms – magic or otherwise – and venture capital money is starting to follow. Today sees the launch of the first investment fund in the UK devoted to psychedelic healthcare, with plans to invest in “revolutionary mind-altering medicines to …

VC fund dedicated to psychedelic meds launches in UK Read More »

Olive Tree Ventures closes $170m dedicated digital health fund

Israel’s specialist venture capital firm, Olive Tree Ventures (OTV) has closed a fund worth $170 million, with plans to expand its portfolio of digital health firms. OTV is the only VC in Israel whose main focus is digital health, specialising in supporting portfolio companies reaching maturity. This includes help with regulatory hurdles and marketing of …

Olive Tree Ventures closes $170m dedicated digital health fund Read More »

Israeli Digital Health VC Firm OTV Closes $170M Venture Fund

What You Should Know: – OTV (formerly Olive Tree Ventures), Israel’s ‘digital health first’ venture capital firm closes $170 million venture fund to support innovative digital health companies worldwide. – OTV also announced today a new China office and the appointment of Jose Antonio Urrutia Rivas as Head of Asia Pacific. OTV (formerly Olive Tree Ventures), Israel’s ‘digital health …

Israeli Digital Health VC Firm OTV Closes $170M Venture Fund Read More »

Recent Executive Hires: CVS Health New President, Cleveland Clinic/Amwell Joint Venture Leadership, Others

Neela Montgomery, EVP & President at CVS Pharmacy/Retail CVS Health Corporation names Neela Montgomery Executive Vice President and President of CVS Pharmacy/Retail, effective November 30, 2020. Montgomery will oversee the company’s 10,000 pharmacies across the United States. Montgomery, currently a Board Partner at venture capital firm Greycroft, most recently served as chief executive officer of …

Recent Executive Hires: CVS Health New President, Cleveland Clinic/Amwell Joint Venture Leadership, Others Read More »

VC firm SR One completes GSK spin-out, raising $500m

Trans-Atlantic biotech venture capital firm SR One has completed its spin-out from GlaxoSmithKline and closed its first fund with $500m in its coffers. The VC built itself a considerable reputation after it was founded in 1985 and works with entrepreneurs and scientists to build biotechnology companies. GSK is the largest investor in the independent fund, …

VC firm SR One completes GSK spin-out, raising $500m Read More »

Peregrine Ventures Launches $300M VC Fund for Late-Stage Life Science Companies

What You Should Know: – Israeli-based Peregrine Ventures launches a new $300 million venture capital fund named Peregrine Growth to focus on late-stage life science companies. – Peregrine Growth will invest $20 to $30 million per funding round, with a strong emphasis on companies that are on the verge of an IPO or M&A.  Peregrine …

Peregrine Ventures Launches $300M VC Fund for Late-Stage Life Science Companies Read More »

Tampa General to Launch Healthcare Innovation Venture Fund in Q1 2021

What You Should Know: – Tampa General Hospital announces its plan to launch a new healthcare innovation venture fund to improve the quality and access to care across the Tampa/St. Pete metro area in Q1 2021. – Through TGH InnoVentures, Tampa General will partner with Embarc Collective, Tampa Bay’s innovation hub and education nonprofit dedicated …

Tampa General to Launch Healthcare Innovation Venture Fund in Q1 2021 Read More »

Kyowa Kirin backs €125m life science fund closed by Fountain Healthcare

Ireland-based Fountain Healthcare Partners has raised another €125 million ($131 million) for its third life sciences fund – 25% ahead of its target – and says it will pump most of the money into European therapeutics and medical device companies. The latest cash injection adds to the €118 million initially raised by Fountain Healthcare for …

Kyowa Kirin backs €125m life science fund closed by Fountain Healthcare Read More »

COVID-19 Pandemic Further Exposes Systemic Racism…

Michael A Greely, Co-Founder & General Partner at Flare Capital Partners This will be ugly and sad. Racism has cost this country $16 trillion over the last twenty years according to a recent Citigroup report. Much of this loss ($13 trillion) was attributed to discriminatory lending practices and the 6.1 million fewer jobs created as a …

COVID-19 Pandemic Further Exposes Systemic Racism… Read More »

Aetion completes $82M Series B round with $19M extension

The healthcare analytics company said it had raised the extension funding from three new investors and would use it to accelerate development of its real-world evidence technology.

CancerIQ Raises $5M to Expand Genetic Cancer Risk Assessment Platform

What You Should Know: – CancerIQ raises $5M in Series A funding led by HealthXVentures to accelerate the growth of its genetic cancer risk assessment platform to identify and manage patients at high risk of cancer. – CancerIQ’s technology enables hospitals to use genomics to personalize the prevention and early detection of cancer. – Two …

CancerIQ Raises $5M to Expand Genetic Cancer Risk Assessment Platform Read More »

How are VCs performing due diligence when they can’t meet startups in person?

In a panel discussion during MedCity INVEST Thursday, investors discussed how the Covid-19 pandemic and social distancing requirements have impacted the way they interact with companies.

Five VCs share how the pandemic has changed investing

Months into the Covid-19 pandemic, the pace of new investments for startups has picked back up. Five VCs shared what’s changed and how they’re working in the midst of the crisis.

A special presentation from J.P. Morgan for MedCity’s INVEST conference [Sponsored]

Pamela Aldsworth, head of VC coverage and managing director at J.P. Morgan, discusses deals and dealmaking during the pandemic and how startups can survive, in a special presentation to mark MedCity News’ annual INVEST conference.

Activ Surgical Raises $15M Advance Autonomous and Collaborative Surgery

What You Should Know: – Digital surgery pioneer Activ Surgical raises $15M in funding led by ARTIS Ventures to accelerate U.S. commercialization and European expansion efforts for its ActiveEdge platform, which enables existing surgical systems, from scopes to robots, to visualize, characterize and track tissue, in real-time beyond today’s human capability.  – ActivSight, is an …

Activ Surgical Raises $15M Advance Autonomous and Collaborative Surgery Read More »

GYANT Raises $13.6M for AI-Enabled Digital Front Door Solution to Drive Patient-Doctor Engagements

What You Should Know: – GYANT raises $13.6M in Series A funding for AI-enabled digital front door solutions to drive meaningful patient-doctor engagement. – The investment will enable GYANT to scale up its product development to meet rapidly increasing market demand and support its exponential customer growth. – Current customers include Intermountain Healthcare, OSF Healthcare, …

GYANT Raises $13.6M for AI-Enabled Digital Front Door Solution to Drive Patient-Doctor Engagements Read More »

Medly Pharmacy Lands $100M to Expand Digital On-Demand Pharmacy Platform

What You Should Know: – Medly Pharmacy raises $100M investment co-led by Volition Capital and Greycroft to propel Medly’s leadership in the $500B+ digital on-demand pharmacy market. – Medly will use the funding to expand its digital on-demand pharmacy platform, enter new markets, and provide category-leading services to patients and partners across the country that …

Medly Pharmacy Lands $100M to Expand Digital On-Demand Pharmacy Platform Read More »

VelosBio raises $137M Series B round to support suite of ROR1-targeting cancer drugs

The company is currently running a Phase I study of its lead candidate, the antibody-drug conjugate VLS-101, in patients with lymphomas and leukemias. It has two additional antibody-drug conjugates and a bispecific antibody in preclinical development.

Register for MedCity INVEST and learn how Covid-19 has shaken up investment trends

Gain insights from the perspectives of healthcare investors from Maverick Ventures, Cultivation Capital, Advocate Aurora Health and Flare Capital on investment trends in 2020 at the online conference July 20-24. Register now and save.